ClinicalTrials.Veeva

Menu

Rehabilitative BCI in Acute Ischemic Stroke

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Stroke, Acute

Treatments

Other: Traditional Physiotherapy protocol
Device: Non-invasive BCI training

Study type

Interventional

Funder types

Other

Identifiers

NCT04704427
LYS[2020]-133

Details and patient eligibility

About

In order to explore the role and expound the mechanism of rehabilitative brain computer interface (BCI)-based training (referred to as the Walk Again Neurorehabilitation protocol) in neurofunctional reconstruction in acute phase of cerebral infarction, the investigators choose non-invasive BCI to study lower limb function of patients with acute cerebral infarction. The investigators evaluate lower limb function, the influence on the central brain functional network and relevant immuno-inflammatory indicators, so that the investigators can explore the therapeutic effect and mechanism in the acute phase of cerebral infarction and provide theoretical bases and feasible guidances for the treatment of post-stroke dyskinesia.

Full description

The participants will be randomly divided into experimental group and control group. The experimental group will receive BCI-based lower limb functional training, 30 minutes per time, 5 times per week, with a 4-week training period; the control group will only receive routine lower limb training, with the same treatment frequency, intensity and duration. Statistical analysis will be performed to compare the relevant evaluation indexes of the experimental group and the control group after treatment and 90 days. In this study, the investigators will use Lower Extremity Fugl-Meyer Assessment (LE-FMA) to comprehensively evaluate the function of lower limbs, Functional Ambulation Category Scale (FAC) and 10-meter walking test (10MWT) for walking ability, modified Barthel index (MBI) for daily living abilities, functional magnetic resonance imaging(fMRI)and near infrared functional brain imaging (NIRS) to evaluate brain function and network reconstruction, the translocator protein(TSPO)-positron emission tomography (PET) and blood immune inflammation indicators to evaluate systemic and intracranial immune status.

Enrollment

40 estimated patients

Sex

All

Ages

35 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The diagnosis of cerebral infarction conforms to the diagnostic criteria of "Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018".
  2. 35 ≤ age ≤ 60 .
  3. Onset (last-seen-well) time to randomization time from 24-72 hours.
  4. First onset.
  5. The lesion is assessed by MRI as a single subcortical infarction of the anterior circulation.
  6. 5 ≤NIHSS≤15 (and 1 ≤6a/b≤3 ).
  7. 1 ≤FAC functional walking scale score ≤ 3.
  8. Signed informed consent from subject or legally authorized representative.

Exclusion criteria

  1. Unstable vital signs.
  2. Progressive stroke.
  3. Patients have received intravenous thrombolysis or endovascular treatment.
  4. Cardiogenic cerebral embolism.
  5. Presence of moderate or higher vascular stenosis or vulnerable plaque based on Imaging assessment.
  6. With other diseases of the nervous system.
  7. With serious diseases of other systems (severe circulatory system, respiratory system, motor system) and other diseases unsuitable for training, such as atrial fibrillation, heart failure, lung infection, severe liver or kidney insufficiency, lower extremity venous thrombosis.
  8. Lower limb dysfunction caused by other reasons, such as fracture, lower limb deformity, etc.
  9. With contraindications in imaging examinations, such as metal implantation, fear of claustrophobia, and severe obesity.
  10. Patient who cannot cooperate with training, such as mental disorders, cognitive dysfunction, Mini-Mental State Examination (MMSE) <21 points, etc.
  11. Other reasons: alcoholism; pregnancy; skull defect; indwelling urinary catheter; vision defects affect training, etc.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups

Rehabilitative BCI training
Experimental group
Description:
The experimental group will receive brain computer interface-based lower limb function training (BCI-LLT), 30 minutes/time, 5 times/week, with a 4-week training period.. The training using the lower limb orthosis targeted the patient's ability to walk.
Treatment:
Device: Non-invasive BCI training
Traditional physical therapy protocol
Active Comparator group
Description:
The control group will only receive traditional physical therapy protocol. The traditional physical therapy protocol of lower limb conducted with the same treatment frequency, intensity and duration of treatment, including muscle strength training, balance training and walking training, etc.
Treatment:
Other: Traditional Physiotherapy protocol

Trial contacts and locations

0

Loading...

Central trial contact

Junwei Hao, MD,PHD; Haijie Liu, MD,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems